FBS, TG, and TChol are increased dramatically in patients with NAFLD, and the levels of liver enzymes, including AST, ALT, and GGTP, are also significantly higher in these groups than in healthy groups. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.